Onconova Therapeutics, Inc.
12 Penns Trail
Newtown, PA 18940
July 7, 2023
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
|Re:||Onconova Therapeutics, Inc.|
Registration Statement on Form S-3
Filed June 30, 2023
File No. 333-273081
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconova Therapeutics, Inc. (the “Company”) hereby requests acceleration of the effective date of the above referenced registration statement, as amended, so that such registration statement may become effective at 4:30 p.m. (Washington, D.C. time) on July 11, 2023, or as soon as practicable thereafter.
|ONCONOVA THERAPEUTICS, INC.|
|By:||/s/ MARK GUERIN|
|Title:||Chief Operating Officer & Chief Financial Officer|